Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Pyxis Oncology
Prudential Tower
800 Boylston Street, Suite 1555
Boston, MA 02199
Phone: 617-351-2575

Pyxis Oncology is an immuno-oncology company focused on developing novel therapies to help patients defeat difficult to treat cancers. Built on the ground-breaking research of Dr. Thomas Gajewski, Pyxis is pursuing promising novel targets derived from the latest insights into the tumor microenvironment. Pyxis has generated preclinical data on these targets and is developing a pipeline of novel antibodies with the potential to help new patient populations not currently served by today's immunotherapies.

Key Contact
David Steinberg
Funding Events

07/17/19 $22,000,000 Series A Agent Capital
John Flavin
Leaps by Bayer
Longwood Fund
03/30/21 $152,000,000 Series B Acuta Capital Partners
Arix Bioscience
BVF Partners
Cormorant Asset Management
HBM Healthcare Investments
Janus Henderson Investors
Perceptive Advisors
Pfizer Venture Investments
RA Capital Management
Ridgeback Capital Management
RTW Investments
Tekla Capital Management

Featured Reading